Investing

Add as a preferred source on Google

Divi’s Laboratories Gains 0.63% on Nov. 17 After Prior Loss

The stock closed at ₹11,150 after a 3.16% decline in the previous session. Divi’s latest reported quarter showed higher income and profit year over year.

Updated 1 min read
A worker enters a pharmaceutical manufacturing campus in Hyderabad, India, beneath an overcast morning sky. / EconoTimes.ai
A worker enters a pharmaceutical manufacturing campus in Hyderabad, India, beneath an overcast morning sky. / EconoTimes.ai

Value Research and Alphave data place Divi’s Laboratories shares at ₹11,150 on Nov. 17, a 0.63% gain after a 3.16% prior-session fall.

The ₹70 gain lifted the price from Nov. 16’s ₹11,080 close. StockAnalysis’ history lists 903,749 shares traded in that session, when the stock fell 3.16%.

A Nov. 7 company release reported consolidated total income of ₹3,770 crore and profit after tax of ₹1,127 crore for the quarter ended Sept. 30. Year-earlier figures were ₹2,860 crore and ₹689 crore, respectively.

During the Nov. 7 earnings call, Whole-Time Director – Commercial Nilima Prasad Divi said any bonus-share decision rested with the board. The filing’s subject was the quarterly and half-year results, and it disclosed no bonus-share authorization.

Related articles

View all